Last week we reported that Russian pharmaceutical company Nanolek was cooperating with Israel’s Teva Pharmaceutical Industries on the production of an active ingredient in Russia.
However, Nanolek has advised that it does not have any collaborations with Teva.
We apologise for the error and the original story has been removed from our website.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze